Serkan Torun

Serkan Torun

Auto-generated profile, based on publicly available information

Serkan Torun

Duzce Universitesi

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

6 June 2020 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
AÖAttila Önmez
Attila Önmez
MAMerve Alpay
Merve Alpay
STSerkan Torun
Serkan Torun
IŞİ. Ethem Şahin
İ. Ethem Şahin
KÖKürşad Öneç
Kürşad Öneç
YDYildiz Degirmenci
Yildiz Degirmenci

12 October 2020 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Closed access
STSerkan Torun
Serkan Torun
BÖBülent Ödemiş
Bülent Ödemiş
MÇMehmet F. Çetin
Mehmet F. Çetin
AÖAttila Önmez
Attila Önmez
OCOrhan Coşkun
Orhan Coşkun
Background: Rectal indomethacin or a topical spray of epinephrine to the papilla of Vater has each shown efficacy alone in the prevention of post–endoscopic retrograde cholangiopancreatography pancreatitis (PEP). We supposed that a submucosal epinephrine injection would be more effective and longer acting than a topical epinephrine spray and therefore would further reduce the incidence of PEP. Patients and Methods: A retrospective analysis was conducted of 412 patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) between January 2017 and December 2019. These patients were divided into 2 groups: the indomethacin group and the indomethacin plus the submucosal epinephrine injection group. The incidence rates and severity of PEP, post-ERCP hyperamylasemia, other outcomes, and any other adverse events were compared between the groups. Results: Baseline demographic and clinical characteristics and procedure-related parameters were similar between the 2 groups. The incidence of PEP was 0.4% in the epinephrine group compared with 5.1% in the indomethacin group (P<0.001). Post-ERCP hyperamylasemia occurred in 24.6% of patients in the indomethacin group, whereas 7.6% of patients in the epinephrine group developed this condition; the difference was significant (P<0.001). Postsphincterotomy bleeding occurred in 5 patients, all of whom were in the indomethacin group (P<0.001). Other adverse events, including arrhythmias, acute coronary events, stroke, or hypertension were not significantly different between the 2 groups. Conclusion: Addition of a submucosal epinephrine injection in conjunction with rectal indomethacin significantly reduced the incidence of PEP, post-ERCP hyperamylasemia, and postsphincterotomy bleeding.

1 January 2024 in The Turkish Journal of Geriatrics
Verified
Journal Article
Closed access
YDYÜKSEL DOĞAN
YÜKSEL DOĞAN
ADAdnan Mesut Dede
Adnan Mesut Dede
MÇMuzaffer Çapar
Muzaffer Çapar
STSerkan Torun
Serkan Torun
Introduction: We aim to present the results, experience, and management of the complications and side effects of nutritional products in geriatric patients (age≥65 years) who underwent percutaneous endoscopic gastrostomy. Materials and Method: Between January 01, 2018, and 31 December 2021 we examined 426 patients from the endoscopy and intensive care units. We assessed their primary diseases, insertion indications, procedural complications (endoscopy unit, patient bedside, surgery-household), consultations in the clinic, and procedural morbidity and mortality. Results: Tubes were successfully placed in 426 patients but could not be inserted in 2 patients. The most common indication was cerebrovascular disease (45.3%) and the most common complication was catheter mobilization 16 (3.7%), primarily due to caregivers after discharge. In one patient, the tube passed through the transverse colon before reaching the stomach. This was noticed during colonoscopy and subsequently removed, after which the wound was closed primarily without any major complications. Wound infection resulting from leakage from the side of the tube, occurred in 12 patients (2.8%). Complications were more frequent in male patients aged > 70 years. The most common side effects of nutritional products in these patients were intolerance and diarrhoea. Conclusion: Percutaneous endoscopic gastrostomy is safe and minimally invasive endoscopic procedure associated with low rate of morbidity. Clinicians can maximize outcomes and identify complications early by being aware of complications and utilizing preventive strategies. Furthermore, they need to be aware of the proper management of nutritional products’ side effects. Keywords: Aged; Endoscopy; Critical Care; Gastrostomy.

5 February 2026 in Digestive Diseases and Sciences
Verified
Journal Article
Open access
PDF file
MÇMehmet Fuat Çetin
Mehmet Fuat Çetin
MGMehmet Emin Gönüllü
Mehmet Emin Gönüllü
EYErman Yekenkurul
Erman Yekenkurul
FGFatih Gürsoy
Fatih Gürsoy
STSerkan Torun
Serkan Torun
Objective Post-ERCP pancreatitis (PEP) is the most common complication of ERCP. Identifying simple and accessible biomarkers to predict PEP risk may enhance patient safety and guide clinical decisions. Material and Methods This retrospective, single-center study included 613 adult patients who underwent ERCP between January 2017 and December 2024. Demographic data, comorbidities, procedural details, and preoperative laboratory parameters were collected from institutional electronic health records. The primary outcome was the development of PEP, defined by standard diagnostic criteria. Results Post-ERCP pancreatitis occurred in 52 patients (8.5%). Demographic characteristics and comorbidities, including age, sex, body mass index, diabetes mellitus, and hypertension, were not significantly associated with PEP. Pancreatic duct cannulation was significantly more frequent among patients with PEP (53.8% vs. 24.8%, p < 0.001) and remained an independent risk factor in multivariable analysis (aOR: 3.05, 95% CI: 1.65–5.64, p < 0.001). Patients who developed PEP had higher preoperative neutrophil-to-lymphocyte ratio (NLR) (3.7 ± 1.9 vs. 2.9 ± 1.5, p = 0.001) and C-reactive protein (CRP) levels (18.5 ± 11.2 vs. 11.4 ± 8.3 mg/L, p = 0.001). In adjusted analysis, both NLR (aOR: 1.14, 95% CI: 1.02–1.28, p = 0.02) and CRP (aOR: 1.04, 95% CI: 1.01–1.08, p = 0.008) remained statistically significant but modest independent predictors of PEP. ROC analysis demonstrated limited discriminative ability for both NLR (AUC: 0.64) and CRP (AUC: 0.66), with moderate sensitivity and specificity. Conclusion Elevated preoperative NLR and CRP levels, together with pancreatic duct cannulation, were independently associated with an increased risk of post-ERCP pancreatitis. Although these inflammatory markers demonstrated statistically significant associations, their predictive strength was modest. Therefore, NLR and CRP should be interpreted as supportive parameters rather than standalone predictors and may contribute to pre-procedural risk stratification when integrated with established clinical and procedural risk factors. Further prospective, multicenter studies are warranted to validate these findings and clarify their role in clinical practice.

23 July 2026 in Health Sciences Quarterly
Verified
Journal Article
Open access
PDF file
AEAli Ümit Eşbah
Ali Ümit Eşbah
STSerkan Torun
Serkan Torun
Sedation during advanced endoscopic procedures is associated with an increased risk of respiratory complications, particularly in obese patients. This study aimed to compare respiratory complications between obese and non-obese patients undergoing advanced endoscopic procedures under sedation and to identify independent predictors of these complications. In this retrospective, single-center cohort study, a total of 104 patients who underwent EUS and/or ERCP under sedation were included. Patients were categorized as obese (BMI ≥30 kg/m², n=52) and non-obese (BMI <30 kg/m², n=52). The primary outcome was hypoxemia (SpO₂ <90%). Secondary outcomes included apnea, airway intervention, and other periprocedural complications. Multivariable logistic regression analysis was performed to identify independent predictors of respiratory complications. Hypoxemia was observed more frequently in obese patients compared to non-obese patients (30.8% vs 15.4%, p=0.048). The lowest recorded SpO₂ values were lower in the obese group (90.8 ± 5.1 vs 93.4 ± 4.2, p=0.006). Airway intervention was required more frequently in obese patients (25.0% vs 11.5%, p=0.048). In multivariable analysis, obesity (OR: 2.18, 95% CI: 1.02-4.66, p=0.044), age, ASA class, and procedure duration were identified as independent predictors of respiratory complications. Sedation strategy was not significantly associated with the outcome. Obesity was identified as an independent risk factor for respiratory complications during advanced endoscopic procedures under sedation. These findings highlight the importance of individualized sedation planning and close respiratory monitoring in obese patients.